AIM: To measure the frequency of DNA methylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) promoter and relate this to any change of gene expression in esophageal squamous cell carcinoma in patients from a region of high incidence in China. METHODS: Cancer cell lines were treated with or without the demethylating reagent 5-aza-2'-deoxycytidine. Methylation of the TIMP3 promoter was assessed in three regions by melt curve analysis and its expression was assessed by real-time RT-PCR. Tumors and proximal resection margins were obtained from 64 patients with esophageal squamous cell carcinoma from a region of high incidence in China. Methylation was assessed by melt curve analysis and expression by immunohistochemistry. RESULTS: Methylation in one of the three promoter regions assessed correlated with gene silencing in esophageal cell lines. A degree of methylation of TIMP3 was found in only four esophageal squamous cell carcinomas, and partial loss of TIMP3 protein expression in just one. CONCLUSION: Methylation and loss of expression of TIMP3 occurs infrequently in esophageal squamous cell carcinoma in a region of high incidence in China.
AIM: To measure the frequency of DNA methylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) promoter and relate this to any change of gene expression in esophageal squamous cell carcinoma in patients from a region of high incidence in China. METHODS: Cancer cell lines were treated with or without the demethylating reagent 5-aza-2'-deoxycytidine. Methylation of the TIMP3 promoter was assessed in three regions by melt curve analysis and its expression was assessed by real-time RT-PCR. Tumors and proximal resection margins were obtained from 64 patients with esophageal squamous cell carcinoma from a region of high incidence in China. Methylation was assessed by melt curve analysis and expression by immunohistochemistry. RESULTS: Methylation in one of the three promoter regions assessed correlated with gene silencing in esophageal cell lines. A degree of methylation of TIMP3 was found in only four esophageal squamous cell carcinomas, and partial loss of TIMP3 protein expression in just one. CONCLUSION: Methylation and loss of expression of TIMP3 occurs infrequently in esophageal squamous cell carcinoma in a region of high incidence in China.
Authors: C A Eads; R V Lord; K Wickramasinghe; T I Long; S K Kurumboor; L Bernstein; J H Peters; S R DeMeester; T R DeMeester; K A Skinner; P W Laird Journal: Cancer Res Date: 2001-04-15 Impact factor: 12.701
Authors: Katherine M Finan; Greg Hodge; Ann M Reynolds; Sandra Hodge; Mark D Holmes; Andrew H Baker; Paul N Reynolds Journal: Lung Cancer Date: 2006-07-24 Impact factor: 5.705
Authors: K E Bachman; J G Herman; P G Corn; A Merlo; J F Costello; W K Cavenee; S B Baylin; J R Graff Journal: Cancer Res Date: 1999-02-15 Impact factor: 12.701
Authors: B Anand-Apte; M S Pepper; E Voest; R Montesano; B Olsen; G Murphy; S S Apte; B Zetter Journal: Invest Ophthalmol Vis Sci Date: 1997-04 Impact factor: 4.799
Authors: J Bian; Y Wang; M R Smith; H Kim; C Jacobs; J Jackman; H F Kung; N H Colburn; Y Sun Journal: Carcinogenesis Date: 1996-09 Impact factor: 4.944
Authors: Malcolm V Brock; Mingzhou Gou; Yoshimitsu Akiyama; Alison Muller; Tsung-Teh Wu; Elizabeth Montgomery; Mari Deasel; Paul Germonpré; Lewis Rubinson; Richard F Heitmiller; Stephen C Yang; Arlene A Forastiere; Stephen B Baylin; James G Herman Journal: Clin Cancer Res Date: 2003-08-01 Impact factor: 12.531
Authors: D G Powe; J L Brough; G I Carter; E M Bailey; W G Stetler-Stevenson; D R Turner; R E Hewitt Journal: Br J Cancer Date: 1997 Impact factor: 7.640
Authors: T Miyazaki; H Kato; M Nakajima; A Faried; J Takita; M Sohda; Y Fukai; S Yamaguchi; N Masuda; R Manda; M Fukuchi; H Ojima; K Tsukada; H Kuwano Journal: Br J Cancer Date: 2004-10-18 Impact factor: 7.640
Authors: Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro Journal: Int J Mol Sci Date: 2020-12-20 Impact factor: 5.923
Authors: Wusheng Yan; Joanna H Shih; Jaime Rodriguez-Canales; Michael A Tangrea; Kris Ylaya; Jason Hipp; Audrey Player; Nan Hu; Alisa M Goldstein; Philip R Taylor; Michael R Emmert-Buck; Heidi S Erickson Journal: BMC Res Notes Date: 2012-01-26
Authors: Eric Smith; Neville J De Young; Sandra J Pavey; Nicholas K Hayward; Derek J Nancarrow; David C Whiteman; B Mark Smithers; Andrew R Ruszkiewicz; Andrew D Clouston; David C Gotley; Peter G Devitt; Glyn G Jamieson; Paul A Drew Journal: Mol Cancer Date: 2008-10-02 Impact factor: 27.401